sentence: ACAN : Aggrecan / cartilage-specific proteoglycan core protein ( CSPCP ) / chondroitin sulfate proteoglycan 1 ; AKT1 : RAC-alpha serine / threonine-protein kinase ; AKT3 : RAC-gamma serine / threonine-protein kinase ; AREG : Amphiregulin ; BMP2 : Bone morphogenetic protein 2 ; BMP6 : Bone morphogenetic protein 6 ; BMP7 : Bone morphogenetic protein 7 ; CAMs : Cell adhesion molecules ; CAV1 : Caveolin-1 ; CCL5 : Chemokine ( C-C motif ) ligand 5 / RANTES ; CCNA1 : Cyclin-A1 ; CDH1 : Cadherin / CAM 120/80 or epithelial cadherin ; CECs : Corneal epithelial cells ; CLDN7 : Claudin-7 ; CNTF : Ciliary neurotrophic factor ; COL2A : Collagen , type II , alpha ; CT-1 : Cardiotrophin 1 ; CTGF : Connective tissue growth factor ; CXCL10 : C-X-C motif chemokine 10 / interferon gamma-induced protein 10 ; CXCL12 : Chemokine ( C-X-C motif ) ligand 12 / stromal cell-derived factor-1 ; CXCR1 : Interleukin 8 receptor , alpha ; CXCR3 : Chemokine receptor CXCR3 ; DCN : Decorin ; DKK1 : Dickkopf-related protein 1 ; ECM : Extracellular matrix ; EDA : Ectodysplasin-A ; EDN1 : Endothelin 1 / preproendothelin-1 ; EGF : Epidermal growth facto ; ELISA : Enzyme-linked immuno sorbent assay ; EREG : Epiregulin ; ERK1 / 2 : Extracellular signal-regulated kinases ; F3 : Platelet tissue factor , factor III , thromboplastin ; FAM3B : Protein FAM3B ; FC : Fold change ; FGF1 : Heparin-binding growth factor 1 ; FGF7 : Keratinocyte growth factor ; FOXA1 : Forkhead box protein A1 / hepatocyte nuclear factor 3-alpha ; FOXA2 : Forkhead box protein A2 / hepatocyte nuclear factor 3-beta ; FOXD3 : Forkhead box D3 ; FOXG1 : Forkhead box protein G1 ; FOXN1 : Forkhead box protein N1 ; FOXO4 : Forkhead box protein O4 ; GDF15 : Growth differentiation factor 15 ; GDF9 : Growth differentiation factor 9 ; GJA1 : Gap junction alpha-1 protein / connexin 43 ; GJB1 : Gap junction beta-1 protein / connexin 32 ; gp130 : Glycoprotein 130 ; HCAM : Homing-associated cell adhesion molecule ; HRAS : Transforming protein p21 ; HSPA9 : Stress-70 protein , mitochondrial ; ICAM1 : Intercellular Adhesion Molecule ( CD54 ) ; IFNE : Interferon epsilon ; IGF2 : Insulin-like growth factor 2 ; IL-11 : Interleukin 11 / adipogenesis inhibitory factor ; IL17 : Interleukin 17 ; IL17F : Interleukin 17 F ; IL18 : Interleukin-18 / interferon-gamma inducing factor ; IL1A : Interleukin-1 alpha ; IL1B : Interleukin 1 beta ; IL1R1 : Interleukin 1 receptor , type I ; IL36RN : Interleukin 36 receptor antagonist ; IL-6 : Interleukin 6 ; IL6R : Interleukin 6 receptor ( CD126 ) ; IL-8 : Interleukin 8 ; INHBA : Inhibin , beta A ; IPA : Ingenuity Pathway Analysis ; IPKB : Ingenuity Pathways Knowledge Base ; ISL1 : Insulin gene enhancer protein ; JAK : Janus kinase ; KAT2B : P300 / CBP-associated factor ( PCAF / K ( lysine ) acetyltransferase 2B ; KITLG : Stem Cell Factor ; KLF4 : Kruppel-like factor 4 ; LAMA1 : Laminin subunit alpha-1 ; LAMA3 : Laminin subunit alpha-3 ; LAMC1 : Laminin subunit gamma-1 ; LEF1 : Lymphoid enhancer-binding factor 1 ; LESCD : LESC deficiency ; LESCs : Limbal epithelial stem cells ; LIF : Leukemia inhibitory factor ; MAP2K : Mitogen-activated protein kinase kinase ; MAP2K1 : Dual specificity mitogen-activated protein kinase kinase 1 ; MAPK : Mitogen-activated protein kinases ; MAPK1 : Mitogen-activated protein kinase 1 ; MAPK14 : Mitogen-activated protein kinase 14 / p38 - α ; MAPK3 : Mitogen-activated protein kinase 3 ; MCAM : Melanoma cell adhesion molecule ; MMP1 : Matrix metalloproteinase-1 / interstitial collagenase ; MMP14 : Matrix metalloproteinase-14 ; MMP3 : Stromelysin-1 / matrix metalloproteinase-3 ; MMP9 : Matrix metallopeptidase 9 ; MMPs : Matrix metalloproteases ; MSCs : Mesenchymal stem cells ; MSX1 : Msh homeobox 1 ; MYOD1 : MyoD ; NCAM1 : Neural Cell Adhesion Molecule ( CD56 ) ; NFKB1 : Nuclear factor NF-kappa-B p105 subunit ; NFKBIA : I κ B α ( nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor , alpha ; NF κ B : NF - κ B ( nuclear factor kappa-light-chain-enhancer of activated B cells ; NOV : Nephroblastoma overexpressed ; NT5E : -5 ′ - nucleotidase ( CD73 ) ; OSGIN1 : Oxidative stress induced growth inhibitor 1 ; OSMR : Oncostatin M receptor ; PLG : Plasmin ; PMEL : Premelanosome protein ; PRKCA : Protein kinase C alpha ; PRKCB : Protein kinase C beta type ; RAF1 : RAF proto-oncogene serine / threonine-protein kinase ; RAR : Retinoic acid receptor ; RMA : Robust microarray analysis ; ROCK2 : Rho-associated protein kinase ; SERPINE1 : Plasminogen activator inhibitor-1 ; SOCS1 : Suppressor of cytokine signaling 1 ; SOCS3 : Suppressor of cytokine signaling 3 ; SOX3 : SRY-related HMG-box 3 ; SOX6 : Transcription factor SOX-6 ; SOX9 : SRY ( sex determining region Y ) - box 9 ; SPP1 : Secreted phosphoprotein 1 ; SRC : Proto-oncogene tyrosine-protein kinase ; STAT : Signal transducer and activator of transcription ; STAT3 : Signal transducer and activator of transcription 3 ; TACs : Transient amplifying cells ; TGFB : Transforming growth factor , beta ; TGFB1 : Transforming growth factor beta 1 ; TGFB2 : Transforming growth factor-beta 2 ; TGFBI : Transforming growth factor , beta-induced ; TGFBR1 : Transforming growth factor , beta receptor I / activin A receptor type II-like kinase ; TGFBR2 : Transforming growth factor , beta receptor II ; THY-1 : Thymocyte differentiation antigen 1 ; TIMP1 : TIMP metallopeptidase inhibitor 1 ; TNF α : Tumor necrosis factor-alpha ; TSP-1 : Thrombospondin 1 ; VCAM : Vascular cell adhesion protein 1 ; VEGF : Vascular endothelial growth factor ; VEGFA : Vascular endothelial growth factor A ; VIM : Vimentin ; WNT1 : Proto-oncogene protein Wnt-1 ; WNT5A : Protein Wnt-5a .